Abstract
Background: Neutrophil to lymphocyte ratio (NLR) is a marker for many inflammatory diseases. Ankylosing spondylitis (AS) is among these inflammatory diseases, and many studies have compared the NLR ratio between patients with AS and healthy controls.
Aim: This study aims to systematically review and analyze the available evidence about the significance of NLR values in AS.
Method: Based on Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines, we searched Embase, Pubmed, ISI Web of Science, and Scopus databases from inception to August 2020 using (“Ankylosing spondyl* ” OR “Bechterew Disease” OR “Rheumatoid Spondylitis”) AND ((neutrophil* AND lymphocyte*) OR NLR) as key terms of the search strategy. Data selection and extraction were conducted separately by two authors. We appraised the included articles according to the Joanna Briggs checklist. Comprehensive Meta-analysis Version 2 was used for analysis and assessment of publication bias. I2 > 75% and p-value < 0.05 were considered significant.
Result: In total, 182 studies resulted from a search in all databases. Duplicate removal, title, abstract, and full-text screening yielded 12 related studies, with 11 included in the meta-analysis. Quality assessment was satisfying in all studies. Pooled difference in NLR means value between patients and controls was 0.38 (95% CI: 0.24-0.52, p-value <0.0001). An I2 of 51% and a Cochran Q test p-value of <0.05 indicated moderate heterogeneity; thus, subgroup analysis had no indication. Publication bias was not significant (Funnel plot with an Egger’s intercept of -0.07; p-value=0.95).
Conclusion: Significant higher amounts of NLR may be strongly indicative of underlying inflammation in AS.
Keywords: Neutrophil to lymphocyte ratio, ankylosing spondylitis, inflammation marker, MOOSE, chronic inflammatory disease, immune response.
[http://dx.doi.org/10.3892/ol.2017.6368] [PMID: 28789346]
[http://dx.doi.org/10.4149/BLL_2015_142] [PMID: 26924141]
[http://dx.doi.org/10.1093/rheumatology/ket387] [PMID: 24324212]
[http://dx.doi.org/10.5152/eurjrheumatol.2014.034] [PMID: 27708888]
[http://dx.doi.org/10.1186/s12891-017-1711-1] [PMID: 28810915]
[PMID: 25962324]
[PMID: 25356158]
[http://dx.doi.org/10.1186/1755-7682-5-2] [PMID: 22281066]
[http://dx.doi.org/10.5606/ArchRheumatol.2015.4837]
[http://dx.doi.org/10.1002/jcla.21768] [PMID: 24849656]
[http://dx.doi.org/10.1002/jcla.21908] [PMID: 26666737]
[http://dx.doi.org/10.1093/jnci/dju124] [PMID: 24875653]
[http://dx.doi.org/10.1111/1756-185X.12582] [PMID: 25900081]
[http://dx.doi.org/10.1586/erc.12.159] [PMID: 23259445]
[http://dx.doi.org/10.1016/j.amjcard.2008.05.006] [PMID: 18773982]
[http://dx.doi.org/10.1016/j.critrevonc.2013.03.010] [PMID: 23602134]
[http://dx.doi.org/10.1002/jso.20329] [PMID: 16118772]
[http://dx.doi.org/10.1016/j.jtcvs.2008.05.046] [PMID: 19185164]
[http://dx.doi.org/10.1016/j.clinre.2012.06.004] [PMID: 22841412]
[PMID: 26823804]
[PMID: 25491611]
[http://dx.doi.org/10.5505/abantmedj.2014.16878]
[http://dx.doi.org/10.1111/apm.12722] [PMID: 28766758]
[PMID: 26827703]
[PMID: 11723675]
[PMID: 33575199]
[http://dx.doi.org/10.1023/B:AGEN.0000029415.62384.ba] [PMID: 15166496]
[http://dx.doi.org/10.1016/S0022-1759(99)00170-2] [PMID: 10618514]
[http://dx.doi.org/10.1016/j.lfs.2013.09.003] [PMID: 24044883]